Incidence and predictors of major perioperative adverse cardiac and cerebrovascular events in non-cardiac surgery.

@article{Sabat2011IncidenceAP,
  title={Incidence and predictors of major perioperative adverse cardiac and cerebrovascular events in non-cardiac surgery.},
  author={Sergi Sabat{\`e} and Anna Mases and N. Guilera and Jaume Canet and Jorge Castillo and Carola Orrego and A. Sabat{\'e} and Guillermina Fita and Fina Parramon and Pilar Paniagua and A. Rodriguez and Manel Sabat{\'e}},
  journal={British journal of anaesthesia},
  year={2011},
  volume={107 6},
  pages={
          879-90
        }
}
BACKGROUND Major adverse cardiac and cerebrovascular events (MACCE) represent the most common cause of serious perioperative morbidity and mortality. Our aim was to identify risk factors for MACCE in a broad surgical population with intermediate-to-high surgery-specific risk and to build and validate a model to predict the risk of MACCE. METHODS A prospective, multicentre study of patients undergoing surgical procedures under general or regional anaesthesia in 23 hospitals. The main outcome… 
Incidence of major adverse cardiac events following non-cardiac surgery.
TLDR
One out of five high-risk patients undergoing non-cardiac surgery will develop one or more MACE within 365 days, and the risk for MACE remains increased for about 5 months after non- Cardiac surgery.
Surgery in Cancer Patients: Risk Factors for Major Adverse Cardiac Events
The major adverse cardiac events (MACE) are a major cause of perioperative death in patients of cancer combined with coronary heart disease. The risk factors of postoperative MACE in this specific
Effects of chronic statin use on 30-day major adverse cardiac and cerebrovascular events after thoracic endovascular aortic repair.
TLDR
In patients undergoing TEVAR, chronic statin use was associated with reduced 30-day MACCEs in non-AAS patients, but not in Aas patients, and it might rather be associated with increased risk of AKI in AAS patients.
Preoperative estimated glomerular filtration rate and the risk of major adverse cardiovascular and cerebrovascular events in non-cardiac surgery.
TLDR
Perioperative MACCE increase with declining eGFR, primarily when <45 ml min(-1) 1.73 m(-2), and the use of preoperative eG FR is recommended for cardiovascular risk assessment.
Non-cardiac surgery in patients with coronary artery disease: risk evaluation and periprocedural management
TLDR
This Review summarizes the current data guiding preoperative risk stratification as well as periprocedural management of patients with CAD undergoing non-cardiac surgery, including those treated with stents.
Incidence of postoperative, major, adverse cardiac events in patients undergoing carotid endarterectomy: A single-center, retrospective study
TLDR
The 7-day incidence ofmajor adverse cardiac events after the carotid endarterectomy was 3.5%.
Biomaker evaluation for major adverse cardiovascular event development in patients undergoing cardiac Surgery
TLDR
It is suggested that postoperative ΔIPF and Δhs-TnT may be useful biomarkers for the identification of patients at risk of MACE development and biomarkers showed elevated values at 24 h compared with those at ICU admission in patients with MACE versus no-MACE.
Adverse Cardiovascular Events Associated With Female Pelvic Reconstructive Surgery.
TLDR
Preexisting ND, congestive heart failure, coagulopathy, electrolyte disturbances, and perioperative transfusions are strongly associated with MACCE, with MI being the most common manifestation.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 52 REFERENCES
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
TLDR
In stable patients undergoing nonurgent major noncardiac surgery, this index can identify patients at higher risk for complications and may be useful for identification of candidates for further risk stratification with noninvasive technologies or other management strategies.
Systematic Review: Prediction of Perioperative Cardiac Complications and Mortality by the Revised Cardiac Risk Index
TLDR
The Revised Cardiac Risk Index did not perform well at predicting cardiac events after vascular noncardiac surgery or at predicting death, and high-quality research is needed in this area of perioperative medicine.
Preoperative and Intraoperative Predictors of Cardiac Adverse Events after General, Vascular, and Urological Surgery
TLDR
In comparison with current risk stratification indices, the inclusion of intraoperative elements improves the ability to predict a perioperative cardiac adverse events (CAE) after noncardiac surgery.
Revised cardiac risk index and postoperative morbidity after elective orthopaedic surgery: a prospective cohort study.
BACKGROUND The revised cardiac risk index (RCRI) is associated strongly with increased cardiac ischaemic risk and perioperative death. Associations with non-cardiac morbidity in non-cardiac surgery
Perioperative myocardial infarction--aetiology and prevention.
  • H. Priebe
  • Medicine, Biology
    British journal of anaesthesia
  • 2005
TLDR
Perioperative plaque stabilization by pharmacological means may be as important in the prevention of PMI as an increase in myocardial oxygen supply or a reduction in myCardial oxygen demand.
Pre-operative risk assessment and risk reduction before surgery.
Multifactorial index of cardiac risk in noncardiac surgical procedures.
TLDR
If validated by prospective application, the multifactorial index may allow preoperative estimation of cardiac risk independent of direct surgical risk.
Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery: a review
TLDR
The best evidence does not support a management strategy of preoperative coronary revascularization before noncardiac surgery, and a proposed diagnostic criteria that reflect the unique features of perioperative MIs is proposed.
...
1
2
3
4
5
...